{"id":8114,"date":"2024-01-21T04:56:03","date_gmt":"2024-01-20T23:26:03","guid":{"rendered":"https:\/\/indianpharmanetwork.co.in\/medicines\/?post_type=product&#038;p=8114"},"modified":"2024-10-04T17:07:54","modified_gmt":"2024-10-04T11:37:54","slug":"opdualag-price-india","status":"publish","type":"product","link":"https:\/\/indianpharmanetwork.co.in\/medicines\/product\/opdualag-price-india\/","title":{"rendered":"OPDUALAG (nivolumab and relatlimab-rmbw) injection"},"content":{"rendered":"<h4>What nivolumab and relatlimab-rmbw is and used for?<\/h4>\n<p>Nilotinib, sold under the brand name Tasigna, is a medication used to treat chronic myelogenous leukemia (CML) which has the Philadelphia chromosome. It may be used both in initial cases of chronic phase CML as well as in accelerated and chronic phase CML that has not responded to imatinib.<\/p>\n<h4>How can 1 go about obtaining OPDUALAG Injection?<\/h4>\n<p>OPDUALAG (nivolumab and relatlimab-rmbw) injection, for intravenous use Initial U.S. Approval: 2022<br \/>\nIf <strong>OPDUALAG (nivolumab and relatlimab-rmbw) injection\u00a0<\/strong>are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n<p><strong>Note:<\/strong><br \/>\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n<h3>Rerefences<\/h3>\n<ul>\n<li class=\"lh-sm small fst-italic\">For OPDUALAG (nivolumab and relatlimab-rmbw)Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions <a class=\"text-decoration-none\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/761234s000lbl.pdf\" target=\"_blank\" rel=\"noopener\">For More Details\u00a0<i class=\"fa fa-angle-double-right\"><\/i><\/a><\/li>\n<li class=\"lh-sm small fst-italic\">Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag (nivolumab and relatlimab) for Treatment of Patients with Unresectable or Metastatic Melanoma\u00a0<a class=\"readmore\" href=\"https:\/\/www.businesswire.com\/news\/home\/20220721005857\/en\/Bristol-Myers-Squibb-Receives-Positive-CHMP-Opinion-Recommending-Approval-for-LAG-3-Blocking-Antibody-Combination-Opdualag-nivolumab-and-relatlimab-for-Treatment-of-Patients-with-Unresectable-or-Metastatic-Melanoma\" target=\"_blank\" rel=\"noopener\">For More Details\u00a0<i class=\"fa fa-angle-double-right\"><\/i><\/a><\/li>\n<li class=\"lh-sm small fst-italic\">Nivolumab Plus Relatlimab Aims to Become Primary Treatment Option for Advanced Melanoma\u00a0<a href=\"https:\/\/www.onclive.com\/view\/nivolumab-plus-relatlimab-aims-to-become-primary-treatment-option-for-advanced-melanoma\" target=\"_blank\" rel=\"noopener\">For More Details\u00a0<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<h2>Brand Name: OPDUALAG Generic Name: (nivolumab and relatlimab-rmbw)<br \/>\nOPDUALAG (nivolumab and relatlimab-rmbw) injection is used to treat as a first-line treatment for melanoma (a type of skin cancer).<\/h2>\n<table border=\"1\" width=\"95%\">\n<tbody>\n<tr>\n<td><strong>Brand Name:<\/strong><\/td>\n<td>OPDUALAG<\/td>\n<\/tr>\n<tr>\n<td><strong>Generic Name:<\/strong><\/td>\n<td>nivolumab and relatlimab-rmbw<\/td>\n<\/tr>\n<tr>\n<td><strong>Strength:<\/strong><\/td>\n<td>Injection: 240 mg of nivolumab and 80 mg of relatlimab per 20 mL (12 mg and 4 mg per mL) in a single-dose vial.<\/td>\n<\/tr>\n<tr>\n<td><strong>Manufacturer:<\/strong><\/td>\n<td>Bristol-Myers Squibb<\/td>\n<\/tr>\n<tr>\n<td><strong>Approved By:<\/strong><\/td>\n<td>EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source Details:\u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/761234s000lbl.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Patient Information<\/strong><\/a><\/p>\n<h4>Access Patient Name Basis Treatment<\/h4>\n<p>If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0<a href=\"https:\/\/indianpharmanetwork.co.in\/about-ipn.php\">IPN<\/a>\u00a0in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely<strong> import OPDUALAG (nivolumab and relatlimab-rmbw) injection\u00a0\u201d ba<\/strong>sed on the information you provide.<\/p>\n<p><strong><a href=\"https:\/\/indianpharmanetwork.co.in\/about-ipn.php\">Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a><\/strong>. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as\u00a0<strong>Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik,<\/strong>\u00a0and various other regions in India.<\/p>\n","protected":false},"featured_media":8158,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":""},"product_brand":[],"product_cat":[177],"product_tag":[386,283,282,385],"class_list":{"0":"post-8114","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-skin","7":"product_tag-melanoma","8":"product_tag-nivolumab-and-relatlimab-rmbw","9":"product_tag-opdualag","10":"product_tag-skin-cancer","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product\/8114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media\/8158"}],"wp:attachment":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media?parent=8114"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_brand?post=8114"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_cat?post=8114"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_tag?post=8114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}